{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T05:45:17Z","timestamp":1787636717023,"version":"build-2736575974"},"reference-count":69,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T00:00:00Z","timestamp":1715040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The prevalence of bronchiectasis among adult Aboriginal Australians is higher than that of non-Aboriginal Australians. However, despite evidence to suggest higher prevalence of bronchiectasis among Aboriginal people in Australia, there is sparce evidence in the literature assessing clinical parameters that may predict survival or mortality in this population.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Aboriginal Australians residing in the Top End Health Service region of the Northern Territory of Australia aged &amp;gt;18 years with chest computed tomography (CT) confirmed bronchiectasis between 2011 and 2020 were included. Demographics, body mass index (BMI), medical co-morbidities, lung function data, sputum microbiology, chest CT scan results, hospital admissions restricted to respiratory conditions and all-cause mortality were assessed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 459 patients were included, of whom 146 were recorded deceased (median age at death 59 years). Among the deceased cohort, patients were older (median age 52 vs. 45 years, <jats:italic>p<\/jats:italic> = 0.023), had a higher prevalence of chronic obstructive pulmonary disease (91 vs. 79%, <jats:italic>p<\/jats:italic> = 0.126), lower lung function parameters (median percentage predicted forced expiratory volume in 1 s 29 vs. 40%, <jats:italic>p<\/jats:italic> = 0.149), a significantly greater proportion cultured non-<jats:italic>Aspergillus<\/jats:italic> fungi (65 vs. 46%, <jats:italic>p<\/jats:italic> = 0.007) and <jats:italic>pseudomonas<\/jats:italic> (46 vs. 28%, <jats:italic>p<\/jats:italic> = 0.007) on sputum microbiology and demonstrated bilateral involvement on radiology. In multivariate models advancing age, prior <jats:italic>pseudomonas<\/jats:italic> culture and Intensive care unit (ICU) visits were associated with increased odds of mortality. Higher BMI, better lung function on spirometry, prior positive sputum microbiology for <jats:italic>Haemophilus<\/jats:italic> and use of inhaled long-acting beta antagonist\/muscarinic agents may have a favourable effect.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The results of this study may be of use to stratify high risk adult Aboriginal patients with bronchiectasis and to develop strategies to prevent future mortality.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2024.1366037","type":"journal-article","created":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T04:31:08Z","timestamp":1715056268000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Factors influencing survival and mortality among adult Aboriginal Australians with bronchiectasis\u2014A 10-year retrospective study"],"prefix":"10.3389","volume":"11","author":[{"given":"Subash S.","family":"Heraganahally","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Gibbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiidheshwar J.","family":"Ravichandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davaadorj","family":"Erdenebayar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asanga","family":"Abeyaratne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Howarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,5,7]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2147\/COPD.S6133","article-title":"The pathophysiology of bronchiectasis.","volume":"4","author":"King","year":"2009","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"E828","DOI":"10.1503\/cmaj.160830","article-title":"Diagnosis and management of bronchiectasis.","volume":"189","author":"Smith","year":"2017","journal-title":"CMAJ."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000032537","article-title":"Mortality and comorbidities in patients with bronchiectasis over a 3-year follow-up.","volume":"101","author":"Mateus","year":"2022","journal-title":"Medicine (Baltimore)."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-86407-8","article-title":"Increased mortality in patients with non-cystic fibrosis bronchiectasis with respiratory comorbidities.","volume":"11","author":"Choi","year":"2021","journal-title":"Sci Rep."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-019-1243-3","article-title":"Mortality risk and causes of death in patients with non-cystic fibrosis bronchiectasis.","volume":"20","author":"Sin","year":"2019","journal-title":"Respir Res."},{"key":"B6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.rmed.2013.12.015","article-title":"Mortality in non-cystic fibrosis bronchiectasis: A prospective cohort analysis.","volume":"108","author":"Goeminne","year":"2014","journal-title":"Respir Med."},{"key":"B7","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.arbres.2022.04.008","article-title":"Factors associated with one year mortality in hospitalised patients with exacerbated bronchiectasis.","volume":"58","author":"Sciosciaa","year":"2022","journal-title":"Arch Bronconeumol."},{"key":"B8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.32480\/rscp.2022.27.1.61","article-title":"Bronchiectasis: Morbidity and mortality in Brazil and its impact on hospitalization rates.","volume":"27","author":"Biatobock","year":"2022","journal-title":"Rev Soc Cient Parag."},{"key":"B9","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/S2213-2600(16)30320-4","article-title":"Comorbidities and the risk of mortality in patients with bronchiectasis: An international multicentre cohort study.","volume":"4","author":"McDonnell","year":"2016","journal-title":"Lancet Respir Med."},{"key":"B10","year":"2016","journal-title":"Estimates of aboriginal and Torres Strait islander Australians."},{"key":"B11","first-page":"42","article-title":"An overview of respiratory disease in indigenous communities: A comparison to the wider Australian population.","volume":"1","author":"McTaggart","year":"2010","journal-title":"Med Stud J Aust."},{"key":"B12","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/ajr.12349","article-title":"Chronic respiratory disease in the regional and remote population of the northern territory top end: A perspective from the specialist respiratory outreach service.","volume":"25","author":"Kruavit","year":"2017","journal-title":"Aust J Rural Health."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2023-001738","article-title":"The \u201cABC\u201d of respiratory disorders among adult indigenous people \u2013 asthma, bronchiectasis and COPD among aboriginal Australians \u2013 a systematic review.","volume":"10","author":"Howarth","year":"2023","journal-title":"BMJ Open Resp Res."},{"key":"B14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2174\/1573398X19666221212164215","article-title":"Bronchiectasis among adult first Nations indigenous people \u2013 a scoping review.","volume":"19","author":"Howarth","year":"2023","journal-title":"Curr Respir Med Rev."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1186\/s12873-022-00570-3","article-title":"Comparison and outcomes of emergency department presentations with respiratory disorders among Australian indigenous and non-indigenous patients.","volume":"22","author":"Heraganahally","year":"2022","journal-title":"BMC Emerg Med."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2022-001295","article-title":"COPD disease knowledge, self-awareness and reasons for hospital presentations among a predominately Indigenous Australian cohort \u2013 a study to explore preventable hospitalization.","volume":"9","author":"Pal","year":"2022","journal-title":"BMJ Open Res Res."},{"key":"B17","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.2147\/COPD.S213947","article-title":"Chronic obstructive pulmonary disease in aboriginal patients of the northern territory of Australia: A landscape perspective.","volume":"14","author":"Heraganahally","year":"2019","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.22605\/RRH6390","article-title":"Bronchiectasis among Australian aboriginal and non-aboriginal patients in the regional and remote population of the northern territory of Australia.","volume":"21","author":"Mehra","year":"2021","journal-title":"Rural Remote Health."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1111\/imj.14718","article-title":"Chronic obstructive pulmonary disease with and without bronchiectasis in Aboriginal Australians \u2013 a comparative study.","volume":"50","author":"Heraganahally","year":"2020","journal-title":"Int Med J."},{"key":"B20","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1111\/resp.13280","article-title":"Bronchiectasis in indigenous and non-indigenous residents of Australia and New Zealand.","volume":"23","author":"Blackall","year":"2018","journal-title":"Respirology."},{"key":"B21","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1183\/09031936.00003709","article-title":"Mortality in bronchiectasis: A long-term study assessing the factors influencing survival.","volume":"34","author":"Loebinger","year":"2009","journal-title":"Eur Respir J."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2021.106370","article-title":"Body mass index as a predictor of mortality in bronchiectasis: A nationwide population-based study.","volume":"180","author":"Lee","year":"2021","journal-title":"Respir Med."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.812775","article-title":"Influence of comorbidities and airway clearance on mortality and outcomes of patients with severe bronchiectasis exacerbations in Taiwan.","volume":"8","author":"Huang","year":"2022","journal-title":"Front Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1111\/imj.16023","article-title":"Correlation of spirometry indices to chest radiology in the diagnosis of chronic airway disease among regional and rural Indigenous Australians.","volume":"53","author":"Howarth","year":"2023","journal-title":"Int Med J."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1080\/17476348.2021.1928496","article-title":"Critical analysis of spirometric patterns in correlation to chest computed tomography among adult Indigenous Australians with chronic airway diseases.","volume":"15","author":"Heraganahally","year":"2021","journal-title":"Expert Rev Respir Med."},{"key":"B26","year":"2018","journal-title":"Ethical conduct in research with aboriginal and Torres Strait islander peoples and communities: Guidelines for researchers and stakeholders."},{"key":"B27","doi-asserted-by":"publisher","first-page":"188","DOI":"10.5694\/mja2.52204","article-title":"Bronchiectasis among indigenous adults in the top end of the northern territory, 2011-2020: A retrospective cohort study.","volume":"220","author":"Gibbs","year":"2024","journal-title":"Med J Aust."},{"key":"B28","doi-asserted-by":"publisher","first-page":"00334","DOI":"10.1183\/23120541.00334-2021","article-title":"Epidemiology and economic burden of bronchiectasis requiring hospitalisation in Singapore.","volume":"7","author":"Phua","year":"2021","journal-title":"ERJ Open Res."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0162282","article-title":"Time trends in hospital admissions for bronchiectasis: Analysis of the Spanish national hospital discharge data (2004 to 2013).","volume":"11","author":"S\u00e1nchez-Mu\u00f1oz","year":"2016","journal-title":"PLoS One."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00611-2022","article-title":"Clinical outcomes of bronchiectasis in India: Data from the EMBARC\/respiratory research network of India registry.","volume":"61","author":"Dhar","year":"2023","journal-title":"Eur Respir J."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0071109","article-title":"Bronchiectasis-associated hospitalizations in Germany, 2005\u20132011: A population-based study of disease burden and trends.","volume":"8","author":"Ringshausen","year":"2013","journal-title":"PLoS One."},{"key":"B32","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1111\/j.1445-5994.2011.02444.x","article-title":"Socioeconomic deprivation, readmissions, mortality and acute exacerbations of bronchiectasis.","volume":"42","author":"Roberts","year":"2012","journal-title":"Intern Med J."},{"key":"B33","first-page":"30","article-title":"Hospital admissions for non-cystic fibrosis bronchiectasis in New Zealand.","volume":"128","author":"Bibby","year":"2015","journal-title":"N Z Med J."},{"key":"B34","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/imj.13739","article-title":"Ethnicity, socioeconomic status and the severity and course of non-cystic fibrosis bronchiectasis.","volume":"48","author":"de Boer","year":"2018","journal-title":"Intern Med J."},{"key":"B35","doi-asserted-by":"crossref","first-page":"00001","DOI":"10.1183\/23120541.00001-2019","article-title":"Predictors of non-cystic fibrosis bronchiectasis in Indigenous adult residents of central Australia: Results of a case\u2013control study.","volume":"5","author":"Einsiedel","year":"2019","journal-title":"ERJ Open Res."},{"key":"B36","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.rmed.2007.11.007","article-title":"Bronchiectasis in Central Australia: A young face to an old disease.","volume":"102","author":"Steinfort","year":"2008","journal-title":"Respir Med."},{"key":"B37","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/ajr.12411","article-title":"Bronchiectasis in the Kimberley region of Western Australia.","volume":"26","author":"Barton","year":"2018","journal-title":"Aust J Rural Health."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1080\/22423982.2021.1946324","article-title":"Acute health care among indigenous patients in Canada: A scoping review.","volume":"80","author":"Vigneault","year":"2021","journal-title":"Int J Circumpol Health."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1016\/j.rmed.2007.02.002","article-title":"Analysis of the factors related to mortality in patients with bronchiectasis.","volume":"101","author":"Onen","year":"2007","journal-title":"Respir Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/014860719001400107","article-title":"Metabolic rate and weight loss in chronic obstructive lung disease.","volume":"14","author":"Wilson","year":"1990","journal-title":"J Parenter Enteral Nutr."},{"key":"B41","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejcdt.2013.01.007","article-title":"Basal metabolic rate in bronchial asthma and chronic obstructive pulmonary disease patients.","volume":"62","author":"Agha","year":"2013","journal-title":"Egypt J Chest Dis Tuberc."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/srep10961","article-title":"The existence of bronchiectasis predicts worse prognosis in patients with COPD.","volume":"5","author":"Mao","year":"2015","journal-title":"Sci Rep."},{"key":"B43","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/resp.13005","article-title":"Patients hospitalized with an infective exacerbation of bronchiectasis unrelated to cystic fibrosis: Clinical, physiological and sputum characteristics.","volume":"22","author":"Venning","year":"2017","journal-title":"Respirology."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2019.101885","article-title":"Low penetrance of antibiotics in the epithelial lining fluid. The role of inhaled antibiotics in patients with bronchiectasis.","volume":"60","author":"Karampitsakos","year":"2020","journal-title":"Pulm Pharmacol Ther."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2023.102283","article-title":"Evaluation of high dose N\u2013 acetylcysteine on airway inflammation and quality of life outcomes in adults with bronchiectasis: A randomised placebo-controlled pilot study.","volume":"84","author":"Jayaram","year":"2023","journal-title":"Pulm Pharmacol Ther."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1007\/s40265-022-01785-1","article-title":"Inhaled corticosteroids in adults with non-cystic fibrosis bronchiectasis: From bench to bedside. A narrative review.","volume":"82","author":"Mart\u00ednez-Garc\u00eda","year":"2022","journal-title":"Drugs."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.2147\/COPD.S311236","article-title":"Inhaled corticosteroid therapy in bronchiectasis is associated with all-cause mortality: A prospective cohort study.","volume":"16","author":"H\u00e5kansson","year":"2021","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"key":"B48","doi-asserted-by":"publisher","first-page":"169","DOI":"10.21037\/jtd-20-1282","article-title":"Effects of treatment with long-acting muscarinic antagonists (LAMA) and long-acting beta-agonists (LABA) on lung function improvement in patients with bronchiectasis: An observational study.","volume":"13","author":"Lee","year":"2021","journal-title":"J Thorac Dis."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02184-2021","article-title":"Tiotropium treatment for bronchiectasis: A randomised, placebo-controlled, crossover trial.","volume":"59","author":"Jayaram","year":"2022","journal-title":"Eur Respir J."},{"key":"B50","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1093\/ije\/26.4.797","article-title":"Hospitalization of aboriginal and non-aboriginal patients for respiratory tract diseases in Western Australia, 1988-1993.","volume":"26","author":"Williams","year":"1997","journal-title":"Int J Epidemiol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1183\/09031936.00026313","article-title":"Multidimensional approach to non-cystic fibrosis bronchiectasis: The FACED score.","volume":"43","author":"Mart\u00ednez-Garc\u00eda","year":"2014","journal-title":"Eur Respir J."},{"key":"B52","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1164\/rccm.201309-1575OC","article-title":"The bronchiectasis severity index. An international derivation and validation study.","volume":"189","author":"Chalmers","year":"2014","journal-title":"Am J Respir Crit Care Med."},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3390\/medsci5020013","article-title":"The bronchiectasis toolbox-A comprehensive website for the management of people with bronchiectasis.","volume":"5","author":"Nicolson","year":"2017","journal-title":"Med Sci (Basel)."},{"key":"B54","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/1754-9485.13295","article-title":"Chest computed tomography findings among adult Indigenous Australians in the northern territory of Australia.","volume":"66","author":"Heraganahally","year":"2022","journal-title":"J Med Imaging Radiat Oncol."},{"key":"B55","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.2147\/JAA.S376213","article-title":"The prevalence of bronchodilator responsiveness \u201casthma\u201d among adult indigenous Australians referred for lung function testing in the top end northern territory of Australia.","volume":"15","author":"Heraganahally","year":"2022","journal-title":"J Asthma Allergy."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1111\/imj.15310","article-title":"Comparison of clinical manifestation among Australian Indigenous and non\u2013 indigenous patients presenting with pleural effusion.","volume":"52","author":"Heraganahally","year":"2022","journal-title":"Int Med J."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1111\/imj.15865","article-title":"Flexible bronchoscopy indications and outcomes between indigenous and non-indigenous patients in the northern territory of Australia.","volume":"53","author":"Seyedshahabedin","year":"2022","journal-title":"Int Med J."},{"key":"B58","doi-asserted-by":"crossref","first-page":"869","DOI":"10.2147\/COPD.S361839","article-title":"Differences in the spirometry parameters between indigenous and non-indigenous patients with COPD: A matched control study.","volume":"17","author":"Sze","year":"2022","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0248900","article-title":"Comparison of diffusing capacity of carbon monoxide (DLCO) and total lung capacity (TLC) between Indigenous Australians and Australian Caucasian adults.","volume":"16","author":"Howarth","year":"2021","journal-title":"PLoS One."},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsz248","article-title":"Sleep apnoea among Australian aboriginal and non\u2013 aboriginal patients in the northern territory of Australia\u2013 a comparative study.","volume":"43","author":"Heraganahally","year":"2020","journal-title":"Sleep."},{"key":"B61","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1111\/1754-9485.13569","article-title":"Significance and prognostication of mediastinal lymph node enlargement on chest computed tomography among adult indigenous Australians.","volume":"67","author":"Doss","year":"2023","journal-title":"J Med Imaging Radiat Oncol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/1754-9485.13593","article-title":"Cystic lung disease in adult Indigenous Australians in the northern territory of Australia.","volume":"68","author":"Mishra","year":"2023","journal-title":"J Med Imaging Radiat Oncol."},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2021-001135","article-title":"Implications of using the GLI-2012, GOLD and Australian COPD-X recommendations in assessing the severity of airflow limitation on spirometry among an Indigenous population with COPD: An indigenous Australians perspective study.","volume":"8","author":"Heraganahally","year":"2021","journal-title":"BMJ Open Respir Res."},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0263744","article-title":"Sex differences in pulmonary function parameters among Indigenous Australians with and without chronic airway disease.","volume":"17","author":"Heraganahally","year":"2022","journal-title":"PLoS One."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/17476348.2021.1847649","article-title":"Lung function parameters among Australian aboriginal \u201capparently healthy\u201d adults: An Australian Caucasian and global lung function initiative (GLI-2012) various ethnic norms comparative study.","volume":"23","author":"Heraganahally","year":"2020","journal-title":"Expert Rev Respir Med."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4269\/ajtmh.23-0393","article-title":"Catastrophic effects of using cannabis via bucket bong in top end northern territory of Australia.","volume":"55","author":"Heraganahally","year":"2023","journal-title":"Am J Trop Med Hyg."},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2022-001508","article-title":"Exploring the appropriateness of prescribing practice of inhaled pharmacotherapy among aboriginal Australians in the top end northern territory of Australia: A retrospective cohort study.","volume":"10","author":"Heraganahally","year":"2023","journal-title":"BMJ Open Resp Res."},{"key":"B68","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.2147\/COPD.S328137","article-title":"The effects of inhaled airway directed pharmacotherapy on decline in lung function parameters among indigenous Australian adults with and without underlying airway disease.","volume":"16","author":"Heraganahally","year":"2021","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"key":"B69","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1111\/ajr.12782","article-title":"Utility and outcomes among indigenous and non-indigenous patients requiring domiciliary oxygen therapy in the regional and rural Australian population.","volume":"29","author":"Heraganahally","year":"2021","journal-title":"Aust J Rural Health."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1366037\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T04:31:28Z","timestamp":1715056288000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1366037\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,7]]},"references-count":69,"alternative-id":["10.3389\/fmed.2024.1366037"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1366037","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,7]]},"article-number":"1366037"}}